Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

[1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor.

Romeo G, Salerno L, Pittalà V, Candido M, Intagliata S, Amata E, Salmona M, Cagnotto A, Rescifina A, Floresta G, Modica MN.

Eur J Med Chem. 2019 Sep 10;183:111690. doi: 10.1016/j.ejmech.2019.111690. [Epub ahead of print]

PMID:
31526973
2.

Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents.

Pittalà V, Vanella L, Maria Platania CB, Salerno L, Raffaele M, Amata E, Marrazzo A, Floresta G, Romeo G, Greish K, Intagliata S, Bucolo C, Sorrenti V.

Future Med Chem. 2019 Jul;11(13):1523-1536. doi: 10.4155/fmc-2018-0448.

PMID:
31469335
3.

Strategies to Improve Resveratrol Systemic and Topical Bioavailability: An Update.

Intagliata S, Modica MN, Santagati LM, Montenegro L.

Antioxidants (Basel). 2019 Jul 25;8(8). pii: E244. doi: 10.3390/antiox8080244. Review.

4.

Characterization of Sigma 1 Receptor Antagonist CM-304 and Its Analog, AZ-66: Novel Therapeutics Against Allodynia and Induced Pain.

Cirino TJ, Eans SO, Medina JM, Wilson LL, Mottinelli M, Intagliata S, McCurdy CR, McLaughlin JP.

Front Pharmacol. 2019 Jun 14;10:678. doi: 10.3389/fphar.2019.00678. eCollection 2019.

5.

Protective Effects of Caffeic Acid Phenethyl Ester (CAPE) and Novel Cape Analogue as Inducers of Heme Oxygenase-1 in Streptozotocin-Induced Type 1 Diabetic Rats.

Sorrenti V, Raffaele M, Vanella L, Acquaviva R, Salerno L, Pittalà V, Intagliata S, Di Giacomo C.

Int J Mol Sci. 2019 May 17;20(10). pii: E2441. doi: 10.3390/ijms20102441.

6.

Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands.

Romeo G, Prezzavento O, Intagliata S, Pittalà V, Modica MN, Marrazzo A, Turnaturi R, Parenti C, Chiechio S, Arena E, Campisi A, Sposito G, Salerno L.

Eur J Med Chem. 2019 Jul 15;174:226-235. doi: 10.1016/j.ejmech.2019.04.056. Epub 2019 Apr 21.

PMID:
31042618
7.

Benzimidazolone-based selective σ2 receptor ligands: Synthesis and pharmacological evaluation.

Intagliata S, Alsharif WF, Mesangeau C, Fazio N, Seminerio M, Xu YT, Matsumoto RR, McCurdy CR.

Eur J Med Chem. 2019 Mar 1;165:250-257. doi: 10.1016/j.ejmech.2019.01.019. Epub 2019 Jan 9.

PMID:
30685525
8.

Solid Lipid Nanoparticles Loading Idebenone Ester with Pyroglutamic Acid: In Vitro Antioxidant Activity and In Vivo Topical Efficacy.

Montenegro L, Panico AM, Santagati LM, Siciliano EA, Intagliata S, Modica MN.

Nanomaterials (Basel). 2018 Dec 29;9(1). pii: E43. doi: 10.3390/nano9010043.

9.

Divergent Cytotoxic and Metabolically Stimulative Functions of Sigma-2 Receptors: Structure-Activity Relationships of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79) Derivatives.

Nicholson HE, Alsharif WF, Comeau AB, Mesangeau C, Intagliata S, Mottinelli M, McCurdy CR, Bowen WD.

J Pharmacol Exp Ther. 2019 Feb;368(2):272-281. doi: 10.1124/jpet.118.253484. Epub 2018 Dec 7.

PMID:
30530624
10.

Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines.

Sorrenti V, Pittalà V, Romeo G, Amata E, Dichiara M, Marrazzo A, Turnaturi R, Prezzavento O, Barbagallo I, Vanella L, Rescifina A, Floresta G, Tibullo D, Di Raimondo F, Intagliata S, Salerno L.

Eur J Med Chem. 2018 Oct 5;158:937-950. doi: 10.1016/j.ejmech.2018.09.048. Epub 2018 Sep 17.

PMID:
30261468
11.

Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation.

Greish KF, Salerno L, Al Zahrani R, Amata E, Modica MN, Romeo G, Marrazzo A, Prezzavento O, Sorrenti V, Rescifina A, Floresta G, Intagliata S, Pittalà V.

Molecules. 2018 May 18;23(5). pii: E1209. doi: 10.3390/molecules23051209.

12.

Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update.

Modica MN, Lacivita E, Intagliata S, Salerno L, Romeo G, Pittalà V, Leopoldo M.

J Med Chem. 2018 Oct 11;61(19):8475-8503. doi: 10.1021/acs.jmedchem.7b01898. Epub 2018 Jun 5.

PMID:
29767995
13.

New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT7 and 5-HT1A receptor ligands: Synthesis, structure-activity relationships, and molecular modeling studies.

Intagliata S, Modica MN, Pittalà V, Salerno L, Siracusa MA, Cagnotto A, Salmona M, Kurczab R, Romeo G.

Bioorg Med Chem. 2017 Feb 1;25(3):1250-1259. doi: 10.1016/j.bmc.2016.12.039. Epub 2016 Dec 27.

PMID:
28063784
14.

Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR.

Intagliata S, Modica MN, Pittalà V, Salerno L, Siracusa MA, Cagnotto A, Salmona M, Romeo G.

Bioorg Med Chem Lett. 2016 Aug 15;26(16):4052-6. doi: 10.1016/j.bmcl.2016.06.080. Epub 2016 Jun 28.

PMID:
27396505
15.

Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT₁A and 5-HT₇ receptor ligands.

Modica MN, Intagliata S, Pittalà V, Salerno L, Siracusa MA, Cagnotto A, Salmona M, Romeo G.

Bioorg Med Chem Lett. 2015 Apr 1;25(7):1427-30. doi: 10.1016/j.bmcl.2015.02.042. Epub 2015 Feb 25.

PMID:
25759032
16.

Structure-activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT(7) and 5-HT(1A) receptor ligands.

Salerno L, Pittalà V, Modica MN, Siracusa MA, Intagliata S, Cagnotto A, Salmona M, Kurczab R, Bojarski AJ, Romeo G.

Eur J Med Chem. 2014 Oct 6;85:716-26. doi: 10.1016/j.ejmech.2014.08.023. Epub 2014 Aug 7.

PMID:
25128671

Supplemental Content

Loading ...
Support Center